[HTML][HTML] Sexually transmitted diseases treatment guidelines, 2015

KA Workowski, GA Bolan… - 2015 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
diseases (STDs) were updated by CDC after consultation with a group of professionals …

[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021

KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

[HTML][HTML] Tendencias en la investigación del virus de papiloma humano en Latinoamérica frente a los países de altos ingresos

JJ Moya-Salazar, VA Rojas-Zumaran - Revista Colombiana de …, 2017 - scielo.org.co
Abstract MOYA-SALAZAR, Jeel Junior and ROJAS-ZUMARAN, Víctor Abraham. Tendencias
en la investigación del virus de papiloma humano en latinoamérica frente a los países de …

Laboratory and clinical aspects of human papillomavirus testing

PKS Chan, MA Picconi, TH Cheung… - Critical reviews in …, 2012 - Taylor & Francis
Human papillomavirus (HPV) infection is associated with a wide spectrum of disease that
ranges from self-limited skin warts to life-threatening cancers. Since HPV plays a necessary …

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study

CA Aitken, HME van Agt, AG Siebers… - BMC medicine, 2019 - Springer
Abstract Background In January 2017, the Dutch cervical cancer screening programme
transitioned from cytomorphological to primary high-risk HPV (hrHPV) DNA screening …

Direct release of test results to patients increases patient engagement and utilization of care

F Pillemer, RA Price, S Paone, GD Martich, S Albert… - PLoS …, 2016 - journals.plos.org
An important focus for meaningful use criteria is to engage patients in their care by allowing
them online access to their health information, including test results. There has been little …

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis

JJ Kim, KT Simms, J Killen, MA Smith, EA Burger… - PLoS …, 2021 - journals.plos.org
Background A nonavalent human papillomavirus (HPV) vaccine has been licensed for use
in women and men up to age 45 years in the United States. The cost-effectiveness of HPV …

Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis

N Van de Velde, MC Boily, M Drolet… - Journal of the …, 2012 - academic.oup.com
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study

E McBride, LAV Marlow, AS Forster… - … journal of cancer, 2020 - Wiley Online Library
We used a cross‐sectional survey to examine short‐term anxiety and distress in women
receiving different results following routine human papillomavirus (HPV) primary testing at …

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …